Helvoet Pharma Deutschland GmbH
Helvoet Pharma Deutschland GmbH, a prominent player in the pharmaceutical and healthcare industry, is headquartered in Germany. Established in 1969, the company has built a strong reputation for its innovative solutions in the development and manufacturing of high-quality pharmaceutical packaging and delivery systems. With a focus on parenteral and oral drug delivery, Helvoet Pharma offers a range of core products, including rubber stoppers, syringes, and other critical components that ensure the safety and efficacy of medications. Their commitment to quality and compliance with stringent regulatory standards sets them apart in the market. Over the years, Helvoet Pharma has achieved significant milestones, solidifying its position as a trusted partner for pharmaceutical companies worldwide. With operational regions extending across Europe and beyond, the company continues to drive advancements in drug delivery technology, contributing to improved patient outcomes.
DitchCarbon Score
How does Helvoet Pharma Deutschland GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helvoet Pharma Deutschland GmbH's score of 44 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Helvoet Pharma Deutschland GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Dätwyler Holding AG, which cascades its climate commitments and performance metrics down to Helvoet Pharma. While Helvoet Pharma does not have its own documented reduction targets or specific climate pledges, it aligns with the sustainability initiatives of its parent company, Dätwyler Holding AG. This includes adherence to the Science Based Targets initiative (SBTi) and other industry-standard climate commitments. As a part of the broader corporate family, Helvoet Pharma is expected to contribute to the overall emissions reduction goals set by Dätwyler Holding AG, although specific targets and achievements at the subsidiary level remain unspecified. The company is positioned within an industry increasingly focused on reducing carbon footprints and enhancing sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 8,115,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 77,970,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Helvoet Pharma Deutschland GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
